Cybin Inc. Common Stock
HELP
주식 순위
#11599
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
주가
$10.30
마지막 동기화: 2026-08-11
시가총액
$638.32M
변동 (1일)
2.88%
변동 (1년)
9,119.52%
국가
CA
거래 Cybin Inc. Common Stock (HELP)
카테고리
Healthcare
Cybin Inc. Common Stock (HELP)의 주가 이력
최고 종가: $0.12 (2023-10-01 기준)
최저 종가: $0.40 (2021-06-01 기준)
최저 종가: $0.40 (2021-06-01 기준)
Cybin Inc. Common Stock의 주가 이력 (2021 ~ 2026)
연간 주가 성과
| 연도 | 성과 |
|---|---|
| 2023 | 81.70% |
| 2022 | -76.32% |
| 2021 | 0.00% |
유사 기업 또는 경쟁사의 주가
| 회사 | 주가 | 변동률 1년% | 국가 |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.73 | -3.85% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
